Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Czechia
Clinical trial register · Czechia

Clinical Trials in Czechia

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1522 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
1522
Studies in scope
all four open statuses
785
Recruiting now
open to new participants
303
Lead sponsors
across recruiting studies
Top sites
Ostrava 1 Prague 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals69 Charles University, Czech Republic56 AstraZeneca51 Eli Lilly and Company48 Merck Sharp & Dohme LLC47 Janssen Research & Development, LLC46 Sanofi40 Pfizer36 AbbVie36 University Hospital Ostrava31 Bristol-Myers Squibb30 Hoffmann-La Roche29 Amgen20 Takeda20 Novo Nordisk A/S18 Boehringer Ingelheim18 General University Hospital, Prague17 Masaryk University16 Institute for Clinical and Experimental Medicine15 argenx12 University Hospital Hradec Kralove12 GlaxoSmithKline12 Brno University Hospital11 Masaryk Memorial Cancer Institute11 Genmab11 St. Anne's University Hospital Brno, Czech Republic11 Bayer11 The Institute of Molecular and Translational Medicine, Czech Republic10 Incyte Corporation10 Palacky University9 University Hospital Olomouc9 UCB Biopharma SRL9 Boston Scientific Corporation8 Biogen8 Alexion Pharmaceuticals, Inc.8 University Hospital, Motol8 Daiichi Sankyo8 Celgene8 BeOne Medicines8 University Hospital Pilsen8 Exelixis7 Abbott Medical Devices7 Institute of Health Information and Statistics of the Czech Republic7 Gilead Sciences7 Faculty Hospital Kralovske Vinohrady7 Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.7 Ipsen7 Loxo Oncology, Inc.7 Regeneron Pharmaceuticals6 European Organisation for Research and Treatment of Cancer - EORTC6 University of Alberta6 Tomas Bata Hospital, Czech Republic5 Biotronik SE & Co. KG5 European Myeloma Network B.V.5 Czech Technical University in Prague5 Acerta Pharma BV5 University of Ostrava4 Immunovant Sciences GmbH4 Swedish Orphan Biovitrum4 Nemocnice AGEL Trinec-Podlesi a.s.4 Charite University, Berlin, Germany4 Medtronic4 Genzyme, a Sanofi Company4 Astellas Pharma Global Development, Inc.4 Seagen, a wholly owned subsidiary of Pfizer4 Alnylam Pharmaceuticals4 ACADIA Pharmaceuticals Inc.4 National Institute of Mental Health, Czech Republic4 Genentech, Inc.3 Zenas BioPharma (USA), LLC3 Military University Hospital, Prague3 Copenhagen University Hospital, Rigshospitalet3 Astria Therapeutics, Inc.3 MoonLake Immunotherapeutics AG3 BTL Industries Ltd.3 EMD Serono Research & Development Institute, Inc.3 Leiden University Medical Center3 Mirati Therapeutics Inc.3 BioNTech SE3 Gustave Roussy, Cancer Campus, Grand Paris3 Xenon Pharmaceuticals Inc.3 Aragon Pharmaceuticals, Inc.3 ADARx Pharmaceuticals, Inc.3 Spyre Therapeutics, Inc.3 Agios Pharmaceuticals, Inc.3 Karyopharm Therapeutics Inc3 Na Homolce Hospital3 Institute of Hematology and Blood Transfusion, Czech Republic3 Insel Gruppe AG, University Hospital Bern3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Tesaro, Inc.3 Viatris Innovation GmbH3 Denali Therapeutics Inc.3 CSL Behring3 Vertex Pharmaceuticals Incorporated3 Ascentage Pharma Group Inc.3 Abivax S.A.3 Arrowhead Pharmaceuticals3 Octapharma3 AOP Orphan Pharmaceuticals AG3 Medtronic Cardiac Ablation Solutions3 Aesculap AG3 Intra-Cellular Therapies, Inc.3 Otsuka Pharmaceutical Development & Commercialization, Inc.3 Stichting European Myeloma Network2 NeuroDerm Ltd.2 Olema Pharmaceuticals, Inc.2 Institute of Spa and Balneology, public research institution2 Seaport Therapeutics2 Mirum Pharmaceuticals, Inc.2 Alfasigma S.p.A.2 Apogee Therapeutics, Inc.2 EyeBiotech Ltd.2 Pharming Technologies B.V.2 Institut de Recherches Internationales Servier2 Kartos Therapeutics, Inc.2 Colorado Prevention Center2 Alkermes, Inc.2 Bluefin Biomedicine, Inc.2 European Society of Cardiology2 University College Dublin2 Niguarda Hospital2 Thomayer University Hospital2 Kailera2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 Universitätsklinikum Hamburg-Eppendorf2 Janssen-Cilag Ltd.2 Celldex Therapeutics2 Insmed Incorporated2 Chugai Pharmaceutical2 Revolution Medicines, Inc.2 Ascletis Pharma (China) Co., Limited2 Heidelberg University2 VectivBio AG2 The Central and Eastern European Gynecologic Oncology Group2 Biohaven Therapeutics Ltd.2 Fresenius Medical Care Deutschland GmbH2 Neurocrine Biosciences2 Cogent Biosciences, Inc.2 Celcuity Inc2 Czech Lymphoma Study Group2 Weill Medical College of Cornell University2 EyePoint Pharmaceuticals, Inc.2 NovoCure GmbH2 NewAmsterdam Pharma2 Anthos Therapeutics, Inc.2 Upstream Bio Inc.2 Ferring Pharmaceuticals2 Merz Therapeutics GmbH2 CardioFocus2 Duke University2 Sun Pharmaceutical Industries Limited2 icometrix2 Arcus Biosciences, Inc.2 University Hospital Muenster2 OrbusNeich2 Kardium Inc.2 Teva Branded Pharmaceutical Products R&D LLC2 Ionis Pharmaceuticals, Inc.2 Pulse Biosciences, Inc.2 Eisai Inc.2 ADC Therapeutics S.A.2 Glycomine, Inc.2 University of Birmingham2 Apellis Pharmaceuticals, Inc.2 VDI Technologies1 Curis, Inc.1 ITM Solucin GmbH1 Guerbet1 Menarini Group1 Janssen Pharmaceutica N.V., Belgium1 Blueprint Medicines Corporation1 Hansa Biopharma AB1 ONL Therapeutics1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 Bicara Therapeutics1 Genexine, Inc.1 Belite Bio, Inc1 KeyBioscience AG1 Aura Biosciences1 MapLight Therapeutics1 University Hospital, Bonn1 Deciphera Pharmaceuticals, LLC1 Kyowa Kirin Pharmaceutical Development Ltd1 M.A. Med Alliance S.A.1 Protagonist Therapeutics, Inc.1 Cellectar Biosciences, Inc.1 Pomeranian Medical University Szczecin1 Taiho Oncology, Inc.1 Ever Neuro Pharma GmbH1 KU Leuven1 Digma Medical Ltd.1 Masarykova Univerzita1 BeiGene1 International CTEPH Association1 PhenoNet, Inc.1 Martin Schrappe1 Alleviant Medical, Inc.1 Cerevance1 IO Biotech1 Western Sydney Local Health District1 Priovant Therapeutics, Inc.1 European Association of Urology Research Foundation1 Palisade Bio1 Axon Therapies, Inc.1 Indiana University1 HUYABIO International, LLC.1 pharmaand GmbH1 Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)1 Womed1 Cortex1 MedSIR1 GT Metabolic Solutions, Inc.1 Centre Hospitalier Universitaire de Liege1 CeleCor Therapeutics1 PedAL BCU, LLC1 Prilenia1 Abiomed Inc.1 Rigel Pharmaceuticals1 Baxalta now part of Shire1 Carl Zeiss Meditec AG1 University of Zurich1 Centre Leon Berard1 Marie Lulková1 Stichting Hemato-Oncologie voor Volwassenen Nederland1 Apollo Therapeutics Ltd1 Oslo University Hospital1 St. Anna Kinderkrebsforschung1 IRCCS San Raffaele1 IRCCS San Raffaele Roma1 Vladimíra Dostálová1 Dompé Farmaceutici S.p.A1 Zuyderland Medisch Centrum1 Intellia Therapeutics1 Associazione Italiana Ematologia Oncologia Pediatrica1 IDEAYA Biosciences1 Mitera Hospital1 Almirall, S.A.1 SecuraBio1 University in Zielona Góra1 BackBeat Medical Inc1 VDyne, Inc.1 University of Massachusetts, Worcester1 EPC Education s.r.o.1 Generate Biomedicines1 Santhera Pharmaceuticals1 medac GmbH1 Javelin Medical1 Friedreich's Ataxia Research Alliance1 Alimentiv Inc.1 UNICANCER1 Ultragenyx Pharmaceutical Inc1 Append Medical Ltd.1 FineHeart1 Dizal Pharmaceuticals1 RHEACELL GmbH & Co. KG1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 iTeos Therapeutics1 AtriCure, Inc.1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 Eikon Therapeutics1 Draig Therapeutics Ltd1 Bausch & Lomb GmbH1 Bambino Gesù Hospital and Research Institute1 ENDOPLY1 Marketa Bonaventurova1 CoreMap Inc.1 European Clinical Research Alliance for Infectious Diseases (ECRAID)1 Janssen Biotech, Inc.1 Stimvia s.r.o.1 Merz Pharmaceuticals GmbH1 SpliSense Ltd.1 Jiangsu HengRui Medicine Co., Ltd.1 Biohaven Pharmaceuticals, Inc.1 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 H. Lundbeck A/S1 Pharmacyclics Switzerland GmbH1 Actelion1 Orchid Pharma Europe GmbH1 Perfect Lens, LLC1 Stealth BioTherapeutics Inc.1 University of California, Davis1 University Hospital Tuebingen1 Field Medical1 Pulmovant, Inc.1 Bellus Health Inc. - a GSK company1 AVEO Pharmaceuticals, Inc.1 Stemline Therapeutics, Inc.1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Philip Morris Products S.A.1 Eagle Pharmaceuticals, Inc.1 Primex ehf1 United Therapeutics1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Philipp Homan1 Instituto Portugues Oncologia de Lisboa Francisco Gentil1 Immunocore Ltd1 Alumis Inc1 BioAegis Therapeutics Inc.1 CatalYm GmbH1 University Medical Center Groningen1 Motol and Homolka University Hospital1 Definium Therapeutics US, Inc.1 Lexicon Pharmaceuticals1 BioCryst Pharmaceuticals1 Manuel Monreal1 SOTIO Biotech a.s.1 Philipp Dutkowski1 Santen SAS1 AriBio Co., Ltd.1 Poitiers University Hospital1 Tenax Therapeutics, Inc.1 University Hospital, Akershus1 X4 Pharmaceuticals1 Faron Pharmaceuticals Ltd1 Gemini Eye Clinic1 LMU Klinikum1 Syndax Pharmaceuticals1 Azienda Unita Sanitaria Locale di Piacenza1 IntraBio Inc1 Annexon, Inc.1 VarmX B.V.1 Foundry Innovation & Research 1, Limited (FIRE1)1 SystImmune Inc.1 University of Cambridge1 Kite, A Gilead Company1 Vojtech Melenovsky, MD, PhD1 The Hospital for Sick Children1 Sitala Bio LTD1 Interni hematologicka klinika FNKV1 University Hospital, Geneva1 Tanabe Pharma America, Inc.1 Gossamer Bio USA, Inc.1 Odyssey Therapeutics, Inc.1 Medical University of Vienna1 Research Maatschap Cardiologen Rotterdam Zuid1 Pierre Fabre Medicament1 Australasian Gastro-Intestinal Trials Group1 Memorial Sloan Kettering Cancer Center1 Rare Thyroid Therapeutics International AB1 Arga Medtech SA1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 AnaCardio AB1 Jazz Pharmaceuticals1 Ancora Heart, Inc.1 Cybin IRL Limited1 St George's, University of London1 Children's Oncology Group1 Martina Lojova1 Princess Maxima Center for Pediatric Oncology1 Cytokinetics1 Orchestra BioMed, Inc1 LinkoCare Life Sciences AB1 JaxBio Ltd1 Xcovery Holdings, Inc.1 Janssen Scientific Affairs, LLC1 Summit Therapeutics1 COMPASS Pathways1 Lipidica, a.s.1 CanariaBio Inc.1 SOTIO Biotech AG1 Emergency Medical Service, Prague1 Silesian Hospital in Opava1 Moleculin Biotech, Inc.1 Calcilytix Therapeutics, Inc., a BridgeBio company1 Eidos Therapeutics, a BridgeBio company1 University Hospital Freiburg1 Italfarmaco1 LUMA Vision Ltd.1 Elena Gurkova1 Inventiva Pharma1 UMC Utrecht1 Hamlet Pharma AB1 4TEEN4 Pharmaceuticals GmbH1 Applied Therapeutics, Inc.1 Universitaire Ziekenhuizen KU Leuven1 AlgoTherapeutix1 European Foundation for Study of Chronic Liver Failure1 Vanda Pharmaceuticals1 Insud Pharma1 Cutting Edge SAS1 Lukas Vanek1 Abcentra1 Zai Lab (Shanghai) Co., Ltd.1 Xentria, Inc.1 National and Kapodistrian University of Athens1 St. Justine's Hospital1 Lexeo Therapeutics1 Alentis Therapeutics AG1 Nemocnice Kolín1 Johnson & Johnson Enterprise Innovation Inc.1 Javier P. Gisbert1 Erasca, Inc.1 Nuvalent Inc.1 ALPFA Medical1 Epics Therapeutics1 Biotest1 KARDI AI Technologies s.r.o.1 Nikola Janovska1 Kymera Therapeutics, Inc.1 Kedrion S.p.A.1 Provention Bio, a Sanofi Company1 Pregnolia AG1 Delcath Systems Inc.1 North Eastern German Society of Gynaecological Oncology1 King's College London1 Vedanta Biosciences, Inc.1 Exciva GmbH1 Gesynta Pharma AB1 Miltenyi Biomedicine GmbH1 Rede Optimus Hospitalar SA1 Sirius Therapeutics Co., Ltd.1 Triveni Bio1 Julius Clinical1 CIATRIX, INC.1 Morten H. Bestle1 Vor Biopharma1 Geron Corporation1 Sanofi Pasteur, a Sanofi Company1 Centre Hospitalier Universitaire de Besancon1 NS Pharma, Inc.1 Pharvaris Netherlands B.V.1 Kura Oncology, Inc.1 PedNet Haemophilia Research Foundation1 Institut Claudius Regaud1 Martin Harazim1 BioVentrix1 College of Physical Education and Sport PALESTRA1 Isabelle Herter-Aeberli1 Shanghai Henlius Biotech1 TG Therapeutics, Inc.1 MRM Health NV1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Philips Clinical & Medical Affairs Global1 Philippe ROUSSELOT1 Dimerix Bioscience Pty Ltd1 eleva GmbH1 International Extranodal Lymphoma Study Group (IELSG)1 Dianthus Therapeutics1 Dr. Yaroslav Winter1 Jan Žatecký1 Britannia Pharmaceuticals Ltd.1 Nektar Therapeutics1 Corvia Medical1 Day One Biopharmaceuticals, Inc.1 Myopowers Medical Technologies France SAS1 The University of Texas Health Science Center, Houston1 Innovacell GmbH1 Luye Pharma Group Ltd.1 Medtronic Cardiac Rhythm and Heart Failure1 Servier Bio-Innovation LLC1 MEBSTER1 Avalyn Pharma Inc.1 Institut Curie1 INNODIA iVZW1 Relay Therapeutics, Inc.1 Grifols Therapeutics LLC1 Chiesi Farmaceutici S.p.A.1 Region Örebro County1 GLSMED Learning Health S.A.1 University Hospital, Gasthuisberg1 Imagine Institute1 Redx Pharma Ltd1 Ono Pharmaceutical Co., Ltd.1 University of Regensburg1 Clear sponsor filter
Site location
Ostrava1 Prague1
All 2 locations
Target enrolment
to

Trials in this register

1 of 1522 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Recruiting
Menarini Group
Phase 2
44
Ostrava, Prague
2025-02-18
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-czechia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,522 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Czechia?

1 of the 1 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 1 studies
PhaseStudiesRecruitingShare
Phase 211100%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Menarini Group11

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Gram Negative Infections (1)
→

Browse trials by site location

Ostrava (1) Prague (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.